GRAIL: Making Strides In Cancer Detection [Seeking Alpha]
GRAIL, Inc. (GRAL)
Company Research
Source: Seeking Alpha
Commercialization has shown progress with international partnerships. Ultimately, the investment case still relies on FDA approval or meaningful further commercial successes. Despite the stock's surge, GRAIL's valuation makes sense at the current level. Getty Images GRAIL, Inc. GRAL ) has been on a strong run. The company's development and commercialization of its cancer screening Galleri test has progressed with positive study results and continued commercial strides, raising faith in the investment case. Yet, a lot of This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Discl
Show less
Read more
Impact Snapshot
Event Time:
GRAL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GRAL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GRAL alerts
High impacting GRAIL, Inc. news events
Weekly update
A roundup of the hottest topics
GRAL
News
- Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025 [Yahoo! Finance]Yahoo! Finance
- GRAIL to Present at the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- GRAIL (NASDAQ:GRAL) was given a new $110.00 price target on by analysts at Morgan Stanley.MarketBeat
- GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- GRAIL to Present at Piper Sandler 37th Annual Healthcare ConferencePR Newswire